Wednesday, Apr 24 2019 | Time 08:07 Hrs(IST)
image
  • IOC unveils medal design for Lausanne 2020 Winter Youth Olympics
  • Train service resumes in Kashmir
  • Barca beat Alaves to move to within 3 points of Liga Santander title
  • Trump meets Twitter CEO Dorsey to discuss social media
  • Russia's Khasan border city boosts security measures ahead of Kim's arrival
  • US ready to delay Butina sentencing if defence needs more time to review evidence - Filing
  • US treasury to decide on Trump tax return request by May 6 - Mnuchin
  • UN Security Council adopts resolution to combat sexual violence in war
  • France denounces attacks against military forces in Mali
  • 45 children killed in Sri Lanka bombings, says UNICEF
  • 169 present nomination papers in MP
  • 169 present nomination papers in MP
  • Anti-Pragya remark; FIR filed
  • Anti-Pragya remark; FIR filed
  • TN Governor lauds Gomathi for gold medal at Asian meet
Business Economy


Morepen Lab’s net profit rises by 179 pc

New Delhi, May 1 (UNI) Morepen Laboratories Limited has reported a 179 per cent rise in its net profit at Rs 7.73-crore and 17.4 per cent rise in its net sales revenue at Rs 141-crore in the fourth quarter (Q4) of fiscal 2016-17.

The net profit and the net sales revenue stood at Rs 2.77-crore and Rs 119.77-crore in the corresponding quarter of the fiscal 2015-16.

Announcing the results, Sushil Suri, Chairman and Managing Director, Morepen Laboratories, said that the company’s expanding global reach assisted in achieving a higher topline in Q4 FY 2016-17. Export sales registered a growth of 29 per cent in Q4 at Rs 73-crore. Sales from domestic operations, however, registered a marginal growth of 7 per cent at Rs 68-crore.

“The bulk drugs (API) segment continued to excel in the quarter by contributing 67 per cent to the company’s total turnover. Morepen Lab’s blockbuster bulk drug Loratadine has once again emerged as a growth accelerator for the company in Q4 FY 2016-17,” he said.

According to Mr Suri, Sales from Loratadine alone increased by 54 per cent in Q4 at Rs 34.35-crore. Total bulk drugs sales in Q4 increased by 21 per cent at Rs 94.35-crore.

OTC (Over the Counter) products and Formulations also recorded good sales numbers for the quarter under consideration. Total sales from OTC products, comprising Burnol & Lemolate, went up by 11 per cent in Q4 FY 2016-17.

“Consistent focus on backward integration, research and process innovation has helped company garner better foothold in the market and company’s vision to invest in the new markets is showing results on the expected lines,” he said.

During the entire financial year 2016-17, Morepen Lab’s net profit grew by 46 per cent at Rs 23.04-crore as against Rs 15.78-crore net profit registered in the previous fiscal. Net sales revenue in FY 2016-17 grew by 21 per cent at Rs 529.18-crore.

The total API business registered a growth of 23 per cent at Rs 340.13-crore, Dr. Morepen Home Diagnostics business registered a growth of 23 per cent at Rs 77.76-crore, formulations business registered a growth of 10 per cent at Rs 26.59-crore and Product Contract Manufacturing and Brand Sharing business grew by 16 per cent at Rs 84.69-crore.
UNI ADP RSA SNU 1539
More News
EaseMyTrip ties Liberty Gen Insurance Ltd: Zero cancellation charges on flight tickets

EaseMyTrip ties Liberty Gen Insurance Ltd: Zero cancellation charges on flight tickets

23 Apr 2019 | 6:06 PM

New Delhi, Apr 23 (UNI) EaseMyTrip, one of the leading online travel aggregators has tied-up with Liberty General Insurance Limited, one of India’s fastest growing general insurance companies, to provide its customers with a unique proposition of Zero Cancellation charges on flight tickets.

see more..
Rupee rises by 5 paise against USD

Rupee rises by 5 paise against USD

23 Apr 2019 | 6:04 PM

Mumbai, Apr 23 (UNI) Rupee on Tuesday rose marginally by five paise to 69.62 against the US Dollars on selling of US Dollars by exporters, dealers at the Forex Market said.

see more..
Sensex ends lower at 3-wk-low of 38,564 88 pts on 3rd day in row

Sensex ends lower at 3-wk-low of 38,564 88 pts on 3rd day in row

23 Apr 2019 | 6:04 PM

Mumbai, Apr 23 (UNI) Extending losses for the third straight session on Tuesday, the BSE Sensex fell by 80.30 points to end volatile session at a three-week-low of 38,564.88 due to persistent sell-off in Telecom, Auto, Power, Realty and Finance stocks amid boiling oil prices after United States warned of sanctions on all buyers of Iranian oil.

see more..
Exhale introduces bladeless ceiling fan in Telangana, AP

Exhale introduces bladeless ceiling fan in Telangana, AP

23 Apr 2019 | 6:02 PM

Hyderabad, Apr 23 (UNI) Chennai-based Exhale Innovations Worldwide Private Limited, a Joint Venture with Exhele Fans LLC USA has entered into Telangana and Andhra Pradesh markets by introducing world’s only bladeless ceiling fan.

see more..
IEPF Authority recovers Rs 1,514 cr depositors’ money from Peerless General Finance

IEPF Authority recovers Rs 1,514 cr depositors’ money from Peerless General Finance

23 Apr 2019 | 5:56 PM

New Delhi, Apr 23 (UNI) In a major success, the Investor Education and Protection Fund (IEPF) Authority has been able to enforce the Peerless General Finance and Investment Company Limited to transfer deposits worth about Rs 1514 crore to IEPF.

see more..
image